Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Banyan Biomarkers, Abbott Ink Deal for Traumatic Brain Injury Biomarkers

Banyan Biomarkers, Abbott Ink Deal for Traumatic Brain Injury Biomarkers

Apr 04, 2019
|
staff reporter

NEW YORK (360Dx) — Banyan Biomarkers announced today that it has nonexclusively licensed its proprietary blood biomarkers of traumatic brain injury (TBI) to Abbott.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Point-of-Care Testing

  1. FDA Revises Emergency Use Authorization for Abbott Point-of-Care SARS-CoV-2 Test

  2. Roche Gets FDA Emergency Use Authorization for Rapid Coronavirus, Flu Test

  3. Blood Collection Firm Tasso Seeking to Enable At-Home Coronavirus Antibody Tests

    Premium

  4. Ortho Clinical Diagnostics Nabs $12.9M BARDA Award for SARS-CoV-2 Antigen, Antibody Tests

  5. Cellex, Gauss Partner on At-Home, Point-of-Care Coronavirus Antigen Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.